Discovery of JNJ-787: An Hpk1 inhibitor that enhances the anti-tumor immunity of anti-PD1 in mice

被引：0
|
作者：
Mevellec, Laurence [2 ]
Descamps, Sophie [2 ]
Adelinet, Christophe [2 ]
Wroblowski, Berthold [1 ]
Vreys, Veronique [1 ]
Valckx, Annemie [1 ]
Boeckx, Inge [1 ]
Van Slycken, Nele [1 ]
Paulussen, Caroline [1 ]
Leclercq, Laurent [1 ]
Verhulst, Tinne [1 ]
Van der Leede, Bas-jan [1 ]
Angibaud, Patrick [2 ]
Meerpoel, Lieven [1 ]
Edwards, James [3 ]
Laquerre, Sylvie [3 ]
Lorenzi, Matt [3 ]
Vialard, Jorge [1 ]
机构：
[1] Janssen Res & Dev, Beerse, Belgium
[2] Janssen Res & Dev, Val De Reuil, France
[3] Janssen Res & Dev, Spring House, PA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2019年 / 257卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
5
引用
收藏
页数：1
相关论文
共 50 条
  • [31] HPK1 inhibitor reinvigorates exhausted tumor-infiltrating CD8 T cells and synergizes with anti-PD-1 blockade in gynecologic malignancies
    Park, Junsik
    Lee, Yong Jae
    Kim, Sunghoon
    Lim, Seungmook
    Park, A. Yeong
    Kim, Jamie Jae Eun
    Lee, Jinhwa
    Kim, Sang Wun
    Park, Su-Hyung
    Lee, Jung-Yun
    CANCER RESEARCH, 2024, 84 (06)
  • [32] PD-1 BLOCKADE ADMINISTERED BEFORE OR AT THE TIME OF T CELL ACTIVATION ENHANCES ANTI-TUMOR IMMUNITY
    Moseman, Jena
    McNeel, Douglas
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A492 - A492
  • [33] Targeting glycosylated PD-1 induces potent anti-tumor immunity
    Wang, Yuhan
    Sun, Linlin
    Yang, Riyao
    Liu, Jielin
    Qiu, Yufan
    Hsu, Jennifer L.
    Cha, Jong-ho
    Chan, Li-Chuan
    Hsu, Jung-Mao
    Lee, Heng-Huan
    Lai, Yun-Ju
    Khoo, Kay-Hooi
    Chung, Ezra M.
    Li, Chia-Wei
    Kim, Yong-Soo
    Park, Andrew H.
    Yang, Yi
    Yoo, Stephen S.
    Hung, Mien-Chie
    CANCER RESEARCH, 2020, 80 (16)
  • [34] The combination of oxaliplatin and anti-PD-1 inhibitor promotes immune cells infiltration and enhances anti-tumor effect of PD-1 blockade in bladder cancer
    Zhao, Zihan
    Liu, Siyang
    Sun, Rui
    Zhu, Wenjie
    Zhang, Yulin
    Liu, Tianyao
    Li, Tianhang
    Jiang, Ning
    Guo, Hongqian
    Yang, Rong
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [35] Methyltransferase-like 3 (METTL3) inhibition potentiates anti-tumor immunity: a novel strategy for improving anti-PD1 therapy
    Anna Brichkina
    Roman Suezov
    Magdalena Huber
    Signal Transduction and Targeted Therapy, 8
  • [36] Methyltransferase-like 3 (METTL3) inhibition potentiates anti-tumor immunity: a novel strategy for improving anti-PD1 therapy
    Brichkina, Anna
    Suezov, Roman
    Huber, Magdalena
    SIGNAL TRANSDUCTION AND TARGETED THERAPY, 2023, 8 (01)
  • [37] Fucoidan enhances the anti-tumor effect of anti-PD-1 immunotherapy by regulating gut microbiota
    Li, Hui
    Dong, Tieying
    Tao, Meng
    Zhao, Haifeng
    Lan, Tongtong
    Yan, Shiyu
    Gong, Xinyi
    Hou, Qilong
    Ma, Xuezhen
    Song, Yang
    FOOD & FUNCTION, 2024, 15 (07) : 3463 - 3478
  • [38] Fungal Depletion Bolsters Anti-Tumor Immune Response Elicited by Anti-PD1 Alone and in Combination with Radiation Therapy
    Stevens, S.
    Jang, J. K.
    Kershaw, K.
    Viramontes, J.
    Dar, T. B.
    Nguyen, A. T.
    Henson, R.
    Guarnerio, J.
    Underhill, D.
    Shiao, S. L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S166 - S166
  • [39] Combination of a novel HDAC6 inhibitor ACY-241 and anti-PD-L1 antibody enhances anti-tumor immunity and cytotoxicity in multiple myeloma
    Ray, A.
    Das, D. S.
    Song, Y.
    Hideshima, T.
    Tai, Y-T
    Chauhan, D.
    Anderson, K. C.
    LEUKEMIA, 2018, 32 (03) : 843 - 846
  • [40] A selective HPK1 inhibitor FB849 reprograms intratumoral immune cells and elicits strong anti-cancer immunity
    Kim, Hyekyoung
    Lim, Seungmook
    Park, A. Yeong
    Lee, Jinhwa
    Kim, Jamie Jae Eun
    Jeon, Seung Hyuck
    Lee, Yong Joon
    Shin, Eui-Cheol
    Kim, Seongkon
    CANCER RESEARCH, 2024, 84 (06)
12345